Regulus Therapeutics
RGLS
#7307
Rank
ยฃ0.42 B
Marketcap
ยฃ6.18
Share price
0.00%
Change (1 day)
435.21%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of March 2025 : ยฃ56.68 Million

According to Regulus Therapeutics's latest financial reports the company's total assets are ยฃ56.68 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ67.08 M177.92%
2023-12-31ยฃ24.13 M-37.49%
2022-12-31ยฃ38.61 M-23.86%
2021-12-31ยฃ50.71 M83.82%
2020-12-31ยฃ27.58 M-14.03%
2019-12-31ยฃ32.09 M45.86%
2018-12-31ยฃ22 M-61.79%
2017-12-31ยฃ57.57 M-29.43%
2016-12-31ยฃ81.57 M-14.31%
2015-12-31ยฃ95.2 M-13.56%
2014-12-31ยฃ0.11 B47.63%
2013-12-31ยฃ74.6 M16.49%
2012-12-31ยฃ64.04 M132.15%
2011-12-31ยฃ27.58 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
ยฃ111.58 B 196,756.71%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ24.30 B 42,781.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ67.25 B 118,537.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ87.75 B 154,703.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ72.04 B 127,000.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
ยฃ45.42 M-19.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ6.05 B 10,584.35%๐Ÿ‡บ๐Ÿ‡ธ USA